Greg Tiao

Division of General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.; Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.

50 publications 2023 – 2026 ORCID

What does Greg Tiao research?

Dr. Tiao studies various aspects of pediatric liver cancers and conditions like hepatoblastoma, which is the most common liver cancer in children. He investigates genetic markers, the effectiveness of different treatments such as minimally invasive surgeries, and the impact of certain proteins on tumor growth. Additionally, his research includes the exploration of how various factors influence survival rates in young cancer patients, as well as the outcomes of complex procedures such as liver transplants.

Key findings

  • About 70% of pediatric liver cancer samples showed a genetic marker called DNAJB1-PKAc, but its reliability as a diagnostic tool is still under scrutiny due to conflicting findings.
  • 95% of children with 10 or more lung tumors at diagnosis were able to clear their tumors through chemotherapy or surgery, suggesting effective treatment options even in advanced cases.
  • The use of total pancreatectomy with islet auto-transplantation led to opioid use dropping from 55% to just 4% within a year for children suffering from chronic pancreatitis, significantly improving their quality of life.

Frequently asked questions

Does Dr. Tiao study pediatric liver cancer?
Yes, Dr. Tiao focuses on hepatoblastoma and other pediatric liver conditions, researching their treatment and diagnostic processes.
What types of surgery does Dr. Tiao incorporate in his research?
He studies minimally invasive surgery techniques and how they can improve surgical outcomes for children with liver tumors.
Is Dr. Tiao's work relevant to liver transplant patients?
Yes, he analyzes outcomes for pediatric patients undergoing liver transplants, exploring how to improve their health after complex surgeries.

Publications in plain English

Outcomes of Fontan patients undergoing combined heart-liver transplantation in pediatric hospitals across the United States.

2026

The Journal of thoracic and cardiovascular surgery

Chappell G, Mehdizadeh-Shrifi A, Turner D, Bondoc A, Evans S +8 more

Plain English
This study examined the outcomes of children who received combined heart-liver transplants after undergoing a specific heart procedure known as Fontan surgery. Out of 34 patients analyzed, 91% survived their hospital stay, and overall one-year survival was 85%, with better rates for those over 18. This is important because it shows that as more patients with this complex heart condition survive into adulthood, successful liver transplants are becoming more common, improving their long-term health prospects.

PubMed

Interdisciplinary vascular reconstructive considerations for pediatric tumors.

2026

Journal of vascular surgery

Stetson A, Gutwein A, Bondoc A, Dasgupta R, Maijub J +2 more

Plain English
This study looked at how to treat solid tumors in children that are close to major blood vessels, which makes them more complicated to manage. It emphasizes the importance of a team approach that includes different specialists and highlights the need for customized treatment plans based on the type of tumor and its growth. Understanding these factors can lead to better treatment strategies and potentially improve outcomes for young patients with these challenging tumors.

PubMed

Investigating the oncogenic role of aberrant EZH2 in hepatoblastoma.

2026

Scientific reports

Glaser K, DePasquale EAK, Berklite L, Hickner BT, Rao P +13 more

Plain English
Researchers studied a type of liver cancer in children called hepatoblastoma to understand what drives its growth. They found that a protein called EZH2 is often overactive in aggressive tumors, suggesting it helps the cancer grow. Targeting EZH2 with specific drugs reduced tumor cell growth and made these cells more sensitive to chemotherapy, making it a potential new target for treating this disease.

PubMed

Survival in children with hepatoblastoma and pulmonary metastatic disease at diagnosis based on extent of metastases and need for surgical clearance.

2026

Journal of pediatric surgery

Polites SF, Vierkant RA, Aldrink JH, Lautz TB, Ragan MV +31 more

Plain English
This study looked at how the number of lung tumors affects survival in children with a liver cancer called hepatoblastoma when they are first diagnosed. Out of 315 patients, those with 10 or more lung tumors had similar survival rates to those with fewer tumors, and most (95%) were able to clear their lung tumors through chemotherapy or surgery. This matters because it shows that even with advanced disease, children can survive long-term, highlighting the importance of treatment options like chemotherapy and surgery.

PubMed

International Society of Paediatric Surgical Oncology (IPSO) Minimally Invasive Surgery (MIS) Guidelines.

2026

Ecancermedicalscience

Fernandez-Pineda I, de Campos Vieira Abib S, Boam T, Aspiazu Salinas D, Michael S +18 more

Plain English
The research focused on creating guidelines for pediatric surgeons on how to use minimally invasive surgery (MIS) when treating children with solid tumors. The guidelines aim to improve treatment across different countries, providing recommendations that consider varying resources and situations. This matters because better surgical practices can lead to improved recovery and outcomes for children facing cancer.

PubMed

Fusionin Non-Fibrolamellar Cancer Cases. Reply to Arif et al. Global Re-Analysis Confirms Absence of theFusion in Hepatoblastoma. Comment on "Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways.2025,, 83".

2026

Cancers

Fleifil Y, Gulati R, Jennings K, Miethke A, Bondoc A +4 more

Plain English
This study looked at a specific genetic marker called DNAJB1-PKAc in samples from pediatric liver cancer patients, particularly those with hepatoblastoma. They found this marker in about 70% of the samples they studied. However, other researchers noted that they didn't find the marker in their hepatoblastoma samples, leading to caution about using it as a reliable diagnostic tool for this type of cancer without further validation. This is important because accurate diagnoses can influence treatment options and outcomes for young cancer patients.

PubMed

Surgical management of liver tumors.

2025

Pediatric blood & cancer

Riehle KJ, Vasudevan SA, Bondoc A, Cuenca AG, Garnier H +6 more

Plain English
This study focuses on how to surgically manage liver tumors in children, particularly hepatoblastoma, which is the most common type of liver cancer in kids. The researchers highlight that 2% of childhood cancers start in the liver, and around 60% of those cases are hepatoblastoma. Understanding these tumors and how to treat them is important because it can improve treatment plans and outcomes for affected children.

PubMed

Racial and Ethnic Survival Disparities in Pediatric Oncology Over Time: An Analysis of the SEER Registry.

2025

Journal of pediatric surgery

Kus NJ, Sahoo S, Laetsch TW, Tiao GM, Mayorga-Carlin M +4 more

Plain English
This study looked at how survival rates for children with cancer have changed over time based on their race and ethnicity. Between 1975 and 2016, survival rates improved for all groups, but not equally: survival for White children increased significantly from 62.7% to 87.5%, while survival for Black children only went up from 59.9% to 80.8%. This matters because it highlights that despite overall improvements in cancer survival rates, there are still larger gaps in outcomes for racial and ethnic minority children, suggesting ongoing disparities that need to be addressed.

PubMed

Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome.

2025

Pediatric blood & cancer

Trobaugh-Lotrario AD, O'Neill AF, Belmonte KA, Malogolowkin MH, Tiao GM +1 more

Plain English
The study looked at children with liver tumors who couldn't join a cancer treatment trial due to various health issues. Out of 55 patients surveyed, 38 had tumors like hepatoblastoma, and many were excluded mainly because of problems with their organ function, such as needing extra oxygen or having kidney issues. This research highlights that these children, particularly those with underlying health conditions, need more focused studies to improve their treatment outcomes.

PubMed

Temporal trends in pediatric cancer mortality: rare cancers lag behind more common cancers.

2025

Pediatric hematology and oncology

Englum BR, Sahoo S, Laetsch TW, Tiao GM, Mayorga-Carlin M +4 more

Plain English
The study looked at survival rates for different types of childhood cancers from 1975 to 2016. It found that while survival for common cancers improved significantly, dropping mortality rates by nearly 75%, rare cancers showed much less progress, with only a 40% drop. This matters because it indicates that more research and attention are needed for rare pediatric cancers to improve outcomes for affected children.

PubMed

Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing data sets.

2025

Genetics in medicine : official journal of the American College of Medical Genetics

Weisburd B, Sharma R, Pata V, Reimand T, Ganesh VS +34 more

Plain English
Researchers created a tool called SMA Finder to help accurately diagnose spinal muscular atrophy (SMA) using genetic data from patients. They tested it on over 200,000 genetic samples and found it to be nearly 100% accurate in diagnosing SMA, including cases that were previously misdiagnosed as other conditions. This tool can significantly speed up the diagnosis process, which is crucial because there are effective treatments for SMA available.

PubMed

Impact of Hepatoblastoma on Infectious Complications Following Pediatric Liver Transplantation.

2025

Pediatric transplantation

Hall AD, Hendricks HA, Bowers KA, Geller JI, Bondoc AJ +5 more

Plain English
This study looked at the effects of hepatoblastoma, a type of liver cancer, on infections in children who received liver transplants. Researchers found that 93% of these patients experienced at least one infection in the year after the transplant, with those having hepatoblastoma suffering more infections on average—5.5 per patient compared to 4.5 for biliary atresia patients and 4 for those with other conditions. This matters because it highlights the need for better infection management for pediatric patients with hepatoblastoma after liver transplants, which could improve their recovery and long-term health outcomes.

PubMed

Management, Trends, and Recommendations for Intra-abdominal Lymphatic Malformations: A Single-Center Retrospective Review.

2025

Journal of pediatric surgery

Vore E, Cooke-Barber J, Brungardt J, Tiao G, Hammill A +3 more

Plain English
This study looked at 56 patients with intra-abdominal lymphatic malformations (ILM), which are abnormal growths in the body's lymphatic system. Most patients had symptoms like abdominal pain (32%) and obstruction (9%), and common treatments included medication (sirolimus) and sclerotherapy, which worked well—67% of those treated with sclerotherapy saw their symptoms go away. The findings highlight that less invasive treatments are effective and should be the first choice for managing ILM, with surgery being reserved for cases where these treatments don't work or in emergencies like bowel obstruction.

PubMed

Real-world Multi-institutional Data From the Midwest Pediatric Surgery Consortium (MWPSC) to Assess the Effect of Delayed Kasai Procedure on Biliary Drainage in Patients With Biliary Atresia.

2025

Journal of pediatric surgery

Farooqui ZA, Hartman SJ, Stetson AE, Schepers EJ, Speck KE +23 more

Plain English
This study looked at how the timing of a surgical procedure called the Kasai operation affects jaundice clearance in infants with a liver condition called biliary atresia. Researchers found that infants who had the surgery at 50 days old or younger were 2.6 times more likely to clear their jaundice within three months compared to those who had the surgery later. The variation in how quickly different hospitals performed the surgery may influence outcomes, highlighting the need for timely treatment to improve the chances of healthy recovery.

PubMed

Intraoperative Pyloric Botulinum Toxin Injection for Post Total Pancreatectomy With Islet Autotransplantation Gastroparesis Improvement in Children.

2025

Journal of pediatric surgery

Gurria JP, Mullapudi B, Lowe CMO, Jenkins T, Ogg MS +4 more

Plain English
This study looked at how injecting botulinum toxin into the pylorus (the part of the stomach that connects to the small intestine) affects children who have undergone a total pancreatectomy with islet autotransplantation (a type of surgery for severe pancreatitis). Researchers compared 20 children who received the injection to 20 who did not, finding that those who had the injection achieved full oral nutrition faster (about 29 days compared to 41 days) and needed fewer days of drainage from a feeding tube (about 7 days compared to 10 days). This is significant because it suggests that botulinum toxin injections can help reduce some of the severe stomach issues that can follow this complex surgery in children.

PubMed

Hepatoblastoma.

2025

Nature reviews. Disease primers

Pio L, O'Neill AF, Woodley H, Murphy AJ, Tiao G +7 more

Plain English
Hepatoblastoma is the most common type of liver cancer found in children, affecting about 1.5 out of every million. Most cases happen in kids around 18 months old, and if caught early, survival rates can exceed 80-90%. This research highlights the importance of early detection and better treatments, as advancements are being made to help children with the disease live longer, healthier lives.

PubMed

Bile acids engage the SIPR-STAT3 signaling axis to modulate regulatory T cell responses in fibrosing cholangiopathies.

2025

Journal of hepatology

Kudira R, Yang ZF, Osuji I, Damen MSMA, Yang Vom Hofe A +21 more

Plain English
This study looked at how bile acids affect certain immune cells (regulatory T cells) in liver diseases like biliary atresia. Researchers found that bile acids can change these immune cells in a way that makes them less effective at protecting the liver. Importantly, reducing bile acids or using specific treatments increased the number of protective immune cells and reduced liver damage in mouse models. This matters because it could lead to new treatments that improve liver health in patients with these diseases.

PubMed

Improved Allele Frequencies in gnomAD through Local Ancestry Inference.

2025

bioRxiv : the preprint server for biology

Kore P, Wilson MW, Tiao G, Chao K, Darnowsky PW +8 more

Plain English
Researchers improved a database that tracks genetic variants by considering the ancestry of individuals instead of just lumping everyone together. They found that in mixed ancestry groups, many genetic variants showed significant differences in frequency, with over 78% showing at least double frequency variations among different ancestries. This approach can lead to better interpretations of genetic tests, potentially changing the classification of some variants from uncertain to benign, which is important for understanding health risks.

PubMed

β-Catenin-Cohesin Ring-CEGRs/ALCDs Axis Activation Contributes to the Development of Hepatoblastoma and Fibrolamellar HCC.

2025

Molecular cancer research : MCR

Fleifil Y, Gulati R, Jennings K, Kycia I, Bondoc A +6 more

Plain English
Researchers studied the role of a specific protein complex in two dangerous liver cancers that affect children and teenagers: hepatoblastoma and fibrolamellar hepatocellular carcinoma. They found that this protein complex is linked to the activation of genes that promote cancer growth, and that it is present at high levels in most cancer samples examined. This matters because targeting the components of this protein complex could lead to new treatments, potentially improving outcomes for young patients with these aggressive cancers.

PubMed

Rare germline variant in NFATC4 associated with familial CLL.

2025

Leukemia

Itchaki G, Bai H, Tiao G, Improgo R, Oppenheimer BE +9 more

PubMed

Oncogenic Role of Aberrant EZH2 in Hepatoblastoma.

2025

bioRxiv : the preprint server for biology

Glaser K, Berklite L, Hickner BT, Rao P, Patel RH +13 more

Plain English
This study focused on hepatoblastoma, the most common liver cancer in children, and found that a specific protein called EZH2 plays a significant role in the cancer's growth, particularly in more aggressive cases. The research showed that higher levels of EZH2 were linked to increased cell division and aggressive tumor behavior in patients. By blocking EZH2 with a drug, researchers were able to slow down the cancer's growth and make it more responsive to chemotherapy, highlighting EZH2 as a promising target for new cancer treatments.

PubMed

Pediatric Liver Transplant: Anatomic, Imaging, and Surgical Considerations-A Report of the Pediatric LI-RADS Working Group, From theSpecial Series on Critical Anatomy.

2025

AJR. American journal of roentgenology

Acord MR, Ro E, Alazraki AL, Bondoc A, Botha J +14 more

Plain English
This research paper focuses on how liver transplants are performed on children, specifically looking at the important medical details and imaging processes that are unique to them. The authors emphasize the use of a system called PRETEXT for assessing tumors in pediatric patients, along with special imaging techniques that help in planning and monitoring surgeries. This study is important because it improves how doctors assess and manage liver transplants in children, ultimately leading to better care and outcomes for young patients with severe liver diseases.

PubMed

Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III Trial.

2025

Annals of surgery

Kastenberg ZJ, Vasudevan SA, Dolmadjian L, Langham MR, Piao J +17 more

Plain English
This research studied how implementing specific surgical guidelines affected treatment outcomes for children with hepatoblastoma, a type of liver cancer, between 2009 and 2018. Out of 226 children enrolled, 93% had surgery to remove tumors, and 65% of the surgeries followed the recommended timing guidelines. Following these guidelines led to better surgery rates without increasing complications, showing that consistent protocols can improve treatment for these young patients.

PubMed

Total pancreatectomy with islet auto-transplantation in pediatric patients results in significantly decreased opioid use, improved long-term pain and quality of life outcomes.

2025

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Hartzell CJ, Gurria JP, Goldschneider KR, Vitale DS, Szabova A +7 more

Plain English
This study looked at the effects of a surgery called total pancreatectomy with islet auto-transplantation (TPIAT) on children suffering from chronic or recurring pancreatitis. The results showed that after the surgery, opioid use dropped dramatically from 55% to just 4% within a year, and by five years, no patients needed opioids. Additionally, 60% of patients who had abdominal pain before the surgery reported complete relief just three months after the procedure, and overall, patients experienced significant improvements in their physical and mental well-being. This is important because it shows that TPIAT can greatly enhance quality of life for children with severe pancreatitis while minimizing their need for pain medication.

PubMed

Improved allele frequencies in gnomAD through local ancestry inference.

2025

Nature communications

Kore P, Wilson MW, Tiao G, Chao K, Darnowsky PW +8 more

Plain English
Researchers studied genetic information from diverse groups to improve how we understand allele frequencies—variations in genes—using enhanced methods. They found that 78.5% of genetic variants in the Admixed American group and 85.1% in the African/African American group had significant differences in allele frequencies based on ancestry. This new approach can change how we interpret some genetic variants in a clinical setting, possibly reclassifying them to indicate they are harmless rather than uncertain, which is important for patient diagnosis and treatment.

PubMed

The role of the minimally invasive surgery in the management of paediatric liver tumours.

2025

Ecancermedicalscience

Stetson A, Gonzalez G, Tiao GM

Plain English
This study looked at how minimally invasive surgery can be used for treating liver tumors in children. Researchers found that techniques like laparoscopic liver biopsy and laparoscopic or robotic liver surgery minimize risks and improve cosmetic results compared to traditional surgery. This matters because these methods can offer safer and less invasive options for young patients, helping them recover more easily and potentially leading to better outcomes.

PubMed

Intrahepatic Cholangiolitis in Cystic Fibrosis (ICCF): An Under-Appreciated Cause of Persistent Cholestasis in Infancy.

2024

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

Bernieh A, Bove K, Garcia V, Tiao G, Lazar L +4 more

Plain English
This study looked at liver problems in infants with cystic fibrosis (CF) who had ongoing jaundice, a condition called cholestasis. Researchers examined liver tissue from 10 infants and found that most showed signs of severe damage and inflammation in the bile ducts. Understanding this condition is important because it provides insights into how CF can impact the liver, helping to identify and manage liver issues in these infants before they become serious problems later in life.

PubMed

Children's Oncology Group's 2023 blueprint for research: Surgery.

2024

Pediatric blood & cancer

Gow KW, Lautz TB, Malek MM, Cost NG, Newman EA +5 more

Plain English
The 2023 research paper from the Children's Oncology Group focuses on the importance of surgery for treating children with solid tumors. It emphasizes that careful and well-timed surgeries are often necessary to help cure these children and that following established guidelines is crucial for success. It also highlights the need for ongoing education and evaluation of new surgical techniques to ensure the best possible care for young patients.

PubMed

EZH2 is a key component of hepatoblastoma tumor cell growth.

2024

Pediatric blood & cancer

Glaser K, Schepers EJ, Zwolshen HM, Lake CM, Timchenko NA +5 more

Plain English
This study focused on a protein called EZH2, which is found in high levels in hepatoblastoma, a type of liver cancer that usually affects children. Researchers discovered that when EZH2 is overactive, it helps cancer cells grow faster by interacting with another protein called β-catenin. Understanding how EZH2 works is important because targeting this protein may lead to new treatments for hepatoblastoma.

PubMed

Inferring compound heterozygosity from large-scale exome sequencing data.

2024

Nature genetics

Guo MH, Francioli LC, Stenton SL, Goodrich JK, Watts NA +15 more

Plain English
This research focused on understanding how two harmful genetic variants in the same gene might affect a person's health. The researchers developed a method that correctly identifies how these variants are inherited in 96% of cases using data from over 125,000 genetic samples. This is important because it can lead to better diagnoses for rare genetic diseases and help doctors make more informed decisions about patient care.

PubMed

A genomic mutational constraint map using variation in 76,156 human genomes.

2024

Nature

Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M +42 more

Plain English
This study examined 76,156 human genomes to create a map showing how mutations are restricted across the entire genome, including both protein-coding and non-coding regions. Researchers found that while protein-coding regions have stronger mutation constraints, certain non-coding areas also play crucial roles in gene regulation and are linked to complex diseases. This understanding helps identify important genetic variations and can improve the way we study genetic factors in human health.

PubMed

Author Correction: A genomic mutational constraint map using variation in 76,156 human genomes.

2024

Nature

Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M +42 more

PubMed

Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma.

2024

Hepatology communications

Gulati R, Lutz M, Hanlon M, Cast A, Karns R +5 more

Plain English
Researchers studied patients with aggressive hepatoblastoma, a type of liver cancer, to understand how it spreads to the lungs. They found that certain cells in the liver tumors, including neuron-like cells and cancer-related cells, are released into the bloodstream and contribute to metastases in the lungs. This discovery is important because blocking a specific pathway involved in this process could lead to new treatments to prevent or slow down lung spread in these patients.

PubMed

Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing datasets.

2024

medRxiv : the preprint server for health sciences

Weisburd B, Sharma R, Pata V, Reimand T, Ganesh VS +34 more

Plain English
Researchers studied a new tool called SMA Finder that can diagnose spinal muscular atrophy (SMA) using different types of genetic data, including exome and panel sequencing, which many medical facilities still use as primary tests. They tested this tool on large datasets and found it correctly identified 29 SMA cases, including 16 known cases and 9 new diagnoses that were confirmed through clinical testing. This is important because SMA is often misdiagnosed as other muscle disorders, and early diagnosis is crucial for effective treatment.

PubMed

Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study.

2024

Pediatric blood & cancer

Kastenberg ZJ, Short SS, Riehle KJ, Utria A, Lautz TB +32 more

Plain English
This study focused on the treatment of a rare liver tumor called undifferentiated embryonal sarcoma in children, analyzing data from 78 patients across 17 hospitals over 30 years. Researchers found that while chemotherapy before surgery led to limited shrinkage of the tumors, it resulted in significant tissue death, and 81% of patients could be successfully operated on. Overall, patients had a 70% chance of living without their disease worsening for four years, and 83% survived over that same period, highlighting the importance of complete surgery for better outcomes.

PubMed

The landscape of regional missense mutational intolerance quantified from 125,748 exomes.

2024

bioRxiv : the preprint server for biology

Chao KR, Wang L, Panchal R, Liao C, Abderrazzaq H +28 more

Plain English
Researchers studied gene mutations known as missense variants, which can change how proteins function. They found that certain areas of genes are more sensitive to these changes, with less than 20% of expected mutations suggesting a higher risk of being harmful, especially in individuals with neurodevelopmental disorders. This is important because it offers new ways to evaluate the potential damage caused by genetic mutations, helping to identify which may lead to health issues.

PubMed

A harmonized public resource of deeply sequenced diverse human genomes.

2024

Genome research

Koenig Z, Yohannes MT, Nkambule LL, Zhao X, Goodrich JK +17 more

Plain English
Researchers studied the genomes of 4,094 individuals from 80 different populations to create a comprehensive resource that includes over 153 million genetic variations. This new collection identifies millions of rare genetic variants that were not previously available, which is important for understanding the genetic diversity among underrepresented groups. This resource can help scientists improve health research and treatments for diverse populations by providing better data for genetic studies.

PubMed

Cholestasis alters polarization and suppressor function of hepatic regulatory T cells.

2024

bioRxiv : the preprint server for biology

Kudira R, Yang ZF, Osuji I, Karns R, Bariya P +19 more

Plain English
This study examined how cholestasis, a condition that affects the liver and bile ducts, impacts a type of immune cell called regulatory T-cells (Tregs). Researchers found that during cholestasis, Tregs change in a way that can reduce their protective abilities, but treating a specific mouse model led to more Tregs and less liver damage. In patients with biliary atresia, those with higher Treg responses had better outcomes, indicating that boosting Treg activity could improve liver health in similar conditions.

PubMed

Specific binding sites on Rhesus rotavirus capsid protein dictate the method of endocytosis inducing the murine model of biliary atresia.

2024

American journal of physiology. Gastrointestinal and liver physiology

Temple H, Donnelly B, Mohanty SK, Mowery S, Poling HM +11 more

Plain English
This study focused on how Rhesus rotavirus (RRV) causes biliary atresia (BA), a serious liver disease in children. Researchers found that a specific part of the virus, called the "SRL" peptide, helps the virus enter liver cells and trigger inflammation, leading to bile duct blockage. They discovered that when this peptide is present, the virus uses a unique method to enter cells, significantly increasing the levels of inflammatory proteins, which are linked to the damage caused by BA. This research matters because it could lead to better anlayzing how the virus causes liver damage and potentially how to prevent it.

PubMed

Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers.

2024

Cancers

Gulati R, Fleifil Y, Jennings K, Bondoc A, Tiao G +3 more

Plain English
This study looked at two serious types of liver cancer in children and tested if a new approach could make the standard treatment, cisplatin, more effective. Researchers found that by adding a drug that inhibits an enzyme called HDAC, cisplatin was better at killing off cancer cells and preventing the formation of new tumor clusters, especially in aggressive cases. This is important because it could lead to more effective treatments that reduce the risk of cancer spreading to other parts of the body, potentially improving survival rates for young patients.

PubMed

Quantifying constraint in the human mitochondrial genome.

2024

Nature

Lake NJ, Ma K, Liu W, Battle SL, Laricchia KM +12 more

Plain English
This study focused on the role of mitochondrial DNA (mtDNA) in health and disease by developing a model to measure harmful genetic changes in mtDNA across a large group of 56,434 people. The researchers found that many harmful mtDNA variations are likely undetected, as their analysis showed a significant loss of expected genetic variation, indicating that certain areas of the mtDNA are particularly important for health. Understanding these variations could help identify genetic factors linked to various diseases, improving our ability to discover harmful changes related to both rare and common health issues.

PubMed

Endoscopic cystostomy and biliary sphincterotomy for choledochoceles: A pediatric case series.

2024

JPGN reports

Saad M, Abu-El-Haija M, Lin TK, Towbin AJ, Trout AT +3 more

Plain English
This study looked at treating choledochoceles, which are a type of cyst in children, using a method called endoscopic cystostomy and biliary sphincterotomy in three patients aged 12 to 13. The researchers found that this approach effectively relieved symptoms like abdominal pain and pancreatitis, with patients showing significant improvement and no recurrence of issues after two years. This treatment option is important because it can safely handle these cysts in kids and helps prevent serious complications over time.

PubMed

DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways.

2024

Cancers

Fleifil Y, Gulati R, Jennings K, Miethke A, Bondoc A +5 more

Plain English
This study looked at a specific protein, DNAJB1-PKAc, found in childhood liver cancers, specifically hepatoblastoma (HBL) and fibrolamellar hepatocellular carcinoma (FLC). Researchers discovered that 70% of the patients with HBL have this protein in their tumors. This is important because the presence of DNAJB1-PKAc seems to change how certain genes behave in the cancer, potentially leading to more aggressive disease and affecting how these cancers might develop in young children.

PubMed

Revision Kasai portoenterostomy: A review of indications and outcomes.

2024

Seminars in pediatric surgery

Stetson A, Bondoc A, Tiao G

Plain English
The study reviewed a surgery called revision Kasai portoenterostomy (KPE), which is done to treat children with a liver condition called biliary atresia when an earlier surgery didn’t work. The research found that revision KPE often helps kids who have problems like recurring jaundice, and those who have this surgery don’t seem to end up worse off in the long term compared to kids who only had the first KPE. This is important because it gives doctors and families information to make better decisions about treatment options, including whether to try the revision or go for a liver transplant.

PubMed

Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma.

2023

Children (Basel, Switzerland)

Farooqui Z, Johnston M, Schepers E, Brewer N, Hartman S +5 more

Plain English
This study looked at the quality of life for children who had surgery for a type of liver cancer called hepatoblastoma, comparing those who had liver transplants to those who had part of their liver removed. Researchers found that both groups reported similar overall quality of life scores, around 73.7 out of 100, but children who had liver resections experienced significantly less anxiety about procedures, reporting 33.47 points less anxiety than those who had transplants. This is important because it highlights that while both treatment options have similar long-term quality of life outcomes, the type of surgery can affect the level of anxiety children feel during treatment.

PubMed

Children's Oncology Group's 2023 blueprint for research: Liver tumors.

2023

Pediatric blood & cancer

O'Neill AF, Meyers RL, Katzenstein HM, Geller JI, Tiao GM +3 more

Plain English
This research focuses on liver tumors in children, which make up about 1% to 2% of all childhood cancers, primarily involving two types: hepatoblastoma and hepatocellular carcinoma. The Children's Oncology Group has found important information from past studies that helps in understanding these diseases and in developing better treatments. The ongoing research aims to improve how doctors categorize the risks of these tumors, enhance the overall care for affected children, and discover new treatment options.

PubMed

Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience.

2023

Cancers

Somers KM, Tabbouche RB, Bondoc A, Towbin AJ, Ranganathan S +2 more

Plain English
This study looked at 30 young children with relapsed or treatment-resistant hepatoblastoma, a type of liver cancer. The researchers found that using a drug called cisplatin during relapse led to a 78.6% survival rate, compared to just 25% for those who did not receive it. This is important because it shows that cisplatin may significantly improve survival chances for these patients, but it also highlights that many experienced hearing loss as a side effect, which raises concerns about treatment-related damage.

PubMed

Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia.

2023

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

Hartman SJ, Weiss MA, Temple HM, Donnelly B, Pasula R +4 more

Plain English
Researchers studied how the lack of a specific receptor (the interferon lambda receptor) affects the severity of a liver disease called biliary atresia in mice. They found that newborn mice without this receptor had a significantly higher chance of developing severe symptoms and dying after being infected with a virus, with 90% showing symptoms and 45% dying. This is important because it highlights the role of interferon lambda in protecting against this disease, which could help improve understanding and treatment for infants at risk of biliary atresia.

PubMed

Critical elements of pediatric liver cancer surgery.

2023

Seminars in pediatric surgery

Kastenberg ZJ, Baertschiger RM, Cuenca AG, Galvan NTN, Lemoine CP +15 more

Plain English
This study looked at how to effectively treat liver cancer in children, focusing on two main types: hepatoblastoma and hepatocellular carcinoma. Researchers found that with better chemotherapy and a clearer understanding of when surgery is needed, survival rates have improved, but performing surgery on young kids remains challenging and can lead to complications. The guidelines created from this research aim to help doctors plan surgeries better and make informed decisions during operations to ensure safer outcomes for their young patients.

PubMed

Advancing the Field of Pediatric Liver Transplantation: Urgent Action Items Identified During the 2022 Society of Pediatric Liver Transplantation Meeting.

2023

Transplantation

Feldman AG, Adams M, Griesemer AD, Horslen S, Kelly B +9 more

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.